ISRCTN43442156已完成不适用
Patient satisfaction, menstrual outcome and costs following blind versus visual second-generation ablation for the treatment of menorrhagia: a randomised controlled trial
HS Grampian Endowments (UK)0 个研究点目标入组 220 人开始时间: 2010年7月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Patients eligible for endometrial ablation and be willing to be randomised to either treatment
- •2. Normal endometrial biopsy results
- •3. Uterine cavity less than 12 cm
- •4. Completed their family, use reliable contraception and otherwise be acceptant of hysterectomy
- •5. A pre-operative ultrasound scan must confirm they are suitable for either MEA or HTA
- •6. Pre-operative data, 1-year and 5-year data will be taken
排除标准
- •1. Desire for further family
- •2. Abnormal endometrial pathology
- •3. Uterine cavity > 12 cm
- •4. Normal or light periods
- •5. Previous classical caesarean section/myomectomy/hysterotomy
- •6. Previous caesarean section scar less than 10 mm
- •7. Acute uterine infection
研究者
相似试验
进行中（未招募）
1 期
Safety, pharmacokinetics and preliminary efficacy study of CFZ533 in patients with lupus nephritisupus NephritisMedDRA version: 20.1Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2017-003230-93-HUovartis Pharma AG60
招募中
2 期
A randomized, placebo-controlled, patient and investigator blinded study investigating the safety, tolerability and preliminary efficacy of 8-week treatment with intra-articular LRX712 to regenerate articular cartilage in patients with mild/moderate knee osteoarthritisOsteoarthritisNL-OMON52598ovartis30
进行中（未招募）
1 期
Study of safety, tolerability and preliminary efficacy of multiple intra-articular LNA043 injections in patients with articular cartilage lesions.Acute cartilage injuriesMedDRA version: 20.0Level: PTClassification code 10031161Term: OsteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-004052-30-DKovartis Pharma AG60
进行中（未招募）
1 期
Study of safety and tolerability and preliminary efficacy of LNA043 in patients undergoing autologous chondrocyte implantation.EUCTR2016-003418-28-ATovartis Pharma AG22
进行中（未招募）
1 期
Study of safety, tolerability and preliminary efficacy of multiple intra-articular LNA043 injections in patients with articular cartilage lesions.Acute cartilage injuriesMedDRA version: 20.0Level: PTClassification code 10031161Term: OsteoarthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-004052-30-SEovartis Pharma AG60